A phase I/II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 dosed Q14D without and with prophylactic G-CSF in non-Hodgkin (NHL) or Hodgkin lymphoma (HL) Meeting Abstract


Authors: O'Connor, O. A.; Gerecitano, J.; Van Deventer, H.; Afanasyev, B.; Hainsworth, J.; Chen, M.; Saikali, K.; Seroogy, J.; Escandon, R.; Wolff, A.; Conlan, M. G.
Abstract Title: A phase I/II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 dosed Q14D without and with prophylactic G-CSF in non-Hodgkin (NHL) or Hodgkin lymphoma (HL)
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 667
Language: English
ACCESSION: WOS:000272725802041
PROVIDER: wos
PUBMED: 22276299
DOI: 10.1182/blood.V114.22.1673.1673
Notes: Meeting Abstract: 1673 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work